A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study.


Journal

Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841

Informations de publication

Date de publication:
03 2021
Historique:
received: 23 01 2020
revised: 01 05 2020
accepted: 25 05 2020
pubmed: 9 7 2020
medline: 4 9 2021
entrez: 9 7 2020
Statut: ppublish

Résumé

Prevalence of obesity and associated diseases, including type 2 diabetes mellitus, dyslipidaemia and non-alcoholic fatty liver disease (NAFLD), are increasing. Underlying mechanisms, especially in humans, are unclear. Bariatric surgery provides the unique opportunity to obtain biopsies and portal vein blood-samples. The BARIA Study aims to assess how microbiota and their metabolites affect transcription in key tissues and clinical outcome in obese subjects and how baseline anthropometric and metabolic characteristics determine weight loss and glucose homeostasis after bariatric surgery. We phenotype patients undergoing bariatric surgery (predominantly laparoscopic Roux-en-Y gastric bypass), before weight loss, with biometrics, dietary and psychological questionnaires, mixed meal test (MMT) and collect fecal-samples and intra-operative biopsies from liver, adipose tissues and jejunum. We aim to include 1500 patients. A subset (approximately 25%) will undergo intra-operative portal vein blood-sampling. Fecal-samples are analyzed with shotgun metagenomics and targeted metabolomics, fasted and postprandial plasma-samples are subjected to metabolomics, and RNA is extracted from the tissues for RNAseq-analyses. Data will be integrated using state-of-the-art neuronal networks and metabolic modeling. Patient follow-up will be ten years. Preoperative MMT of 170 patients were analysed and clear differences were observed in glucose homeostasis between individuals. Repeated MMT in 10 patients showed satisfactory intra-individual reproducibility, with differences in plasma glucose, insulin and triglycerides within 20% of the mean difference. The BARIA study can add more understanding in how gut-microbiota affect metabolism, especially with regard to obesity, glucose metabolism and NAFLD. Identification of key factors may provide diagnostic and therapeutic leads to control the obesity-associated disease epidemic.

Identifiants

pubmed: 32640105
doi: 10.1111/joim.13157
pmc: PMC7984244
doi:

Substances chimiques

Biomarkers 0
Insulin 0
Triglycerides 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

340-354

Informations de copyright

© 2020 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.

Références

Nucleic Acids Res. 2013 Apr;41(8):4378-91
pubmed: 23444143
Surg Obes Relat Dis. 2019 Feb;15(2):200-210
pubmed: 30797718
Surg Endosc. 2009 Jul;23(7):1640-4
pubmed: 19057954
Obes Surg. 2016 Dec;26(12):2891-2898
pubmed: 27138602
PLoS Med. 2020 Mar 9;17(3):e1003051
pubmed: 32150549
Diabetes. 2003 May;52(5):1098-103
pubmed: 12716738
Diabetes Res Clin Pract. 2005 Jul;69(1):29-35
pubmed: 15955385
Clin Transl Gastroenterol. 2018 May 25;9(5):155
pubmed: 29799027
N Engl J Med. 2017 Sep 21;377(12):1143-1155
pubmed: 28930514
Hepatology. 2012 Nov;56(5):1751-9
pubmed: 22707395
Eur J Clin Nutr. 2017 Apr;71(4):441-449
pubmed: 27804961
Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1777-82
pubmed: 17267599
Mol Metab. 2017 Nov;6(11):1493-1502
pubmed: 29107295
Gut. 2015 Nov;64(11):1744-54
pubmed: 25500202
Diabetes. 2005 Nov;54(11):3265-73
pubmed: 16249454
Am J Clin Nutr. 2011 Dec;94(6):1399-409
pubmed: 22030226
Obes Surg. 2016 Jul;26(7):1448-56
pubmed: 26613757
Cell Metab. 2017 Oct 3;26(4):611-619.e6
pubmed: 28978426
Nature. 2006 Dec 21;444(7122):1022-3
pubmed: 17183309
Diabetologia. 2006 Sep;49(9):2136-43
pubmed: 16819611
Obes Surg. 2006 Jun;16(6):787-94
pubmed: 16756745
Int J Obes (Lond). 2008 Sep;32(9):1431-7
pubmed: 18607383
Diabetologia. 1996 Mar;39(3):298-305
pubmed: 8721775
Cell Host Microbe. 2008 Apr 17;3(4):213-23
pubmed: 18407065
N Engl J Med. 2007 Aug 23;357(8):741-52
pubmed: 17715408
J Intern Med. 2021 Mar;289(3):340-354
pubmed: 32640105
N Engl J Med. 2004 Dec 23;351(26):2683-93
pubmed: 15616203
J Clin Endocrinol Metab. 2007 Dec;92(12):4678-85
pubmed: 17895322
Obes Rev. 2011 May;12(5):e257-72
pubmed: 20880129
Int J Obes Relat Metab Disord. 2000 Jan;24(1):38-48
pubmed: 10702749
Cell Metab. 2015 Aug 4;22(2):228-38
pubmed: 26244932
Nature. 2012 Sep 13;489(7415):242-9
pubmed: 22972297
JAMA. 2004 Oct 13;292(14):1724-37
pubmed: 15479938
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Biotechnol J. 2013 Sep;8(9):985-96
pubmed: 23613448
Am J Public Health. 2015 Sep;105(9):e54-9
pubmed: 26180980
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369
pubmed: 29503172
Surg Obes Relat Dis. 2019 Apr;15(4):656-665
pubmed: 30824335
Am J Hypertens. 2009 Apr;22(4):378-83
pubmed: 19180062
Diabetes Care. 2004 Jun;27(6):1487-95
pubmed: 15161807
Surg Obes Relat Dis. 2016 Jan;12(1):199-209
pubmed: 26802225
Obes Surg. 2015 Apr;25(4):666-72
pubmed: 25204408

Auteurs

C C Van Olden (CC)

From the, Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Experimental Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.

A W Van de Laar (AW)

Department of Surgery, Spaarne Gasthuis, Hoofddorp, The Netherlands.

A S Meijnikman (AS)

From the, Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.

O Aydin (O)

From the, Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.

N Van Olst (N)

From the, Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.

J B Hoozemans (JB)

From the, Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.

L M De Brauw (LM)

Department of Surgery, Spaarne Gasthuis, Hoofddorp, The Netherlands.

S C Bruin (SC)

Department of Surgery, Spaarne Gasthuis, Hoofddorp, The Netherlands.

Y I Z Acherman (YIZ)

Department of Surgery, Spaarne Gasthuis, Hoofddorp, The Netherlands.

J Verheij (J)

Department of Pathology, Amsterdam UMC, Amsterdam, The Netherlands.

J E Pyykkö (JE)

Department of Health Psychology, Groningen UMC, Groningen, The Netherlands.

M Hagedoorn (M)

Department of Health Psychology, Groningen UMC, Groningen, The Netherlands.

R Sanderman (R)

Department of Health Psychology, Groningen UMC, Groningen, The Netherlands.

N C Bosma (NC)

From the, Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.

V Tremaroli (V)

Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Goteborg, Sweden.

A Lundqvist (A)

Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Goteborg, Sweden.

L E Olofsson (LE)

Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Goteborg, Sweden.

H Herrema (H)

Department of Experimental Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.

D Lappa (D)

Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.

S Hjorth (S)

Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Kobenhavn, Denmark.

J Nielsen (J)

Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.

T Schwartz (T)

Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Kobenhavn, Denmark.

A K Groen (AK)

Department of Experimental Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.

M Nieuwdorp (M)

From the, Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Experimental Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.

F Bäckhed (F)

Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Goteborg, Sweden.
Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Kobenhavn, Denmark.
Department of Clinical Physiology, Region Västtra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

V E A Gerdes (VEA)

From the, Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH